A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 07 Oct 2016 Status changed from active, no longer recruiting to completed.
- 19 Aug 2016 New trial record
- 16 Aug 2016 Status changed from recruiting to active,no longer recruiting.